CDR2 Antibodies

Santa Cruz Biotechnology offers a broad range of CDR2 Antibodies for advanced research in the field of neuroscience and cellular signaling. CDR2 Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CDR2, or cerebellar degeneration-related protein 2, plays a crucial role in neuronal function and is implicated in the regulation of synaptic transmission and plasticity. CDR2 expression is particularly significant in the cerebellum, where it is involved in motor coordination and cognitive processes. Understanding CDR2 function is essential for elucidating the mechanisms underlying neurodegenerative diseases and developing potential therapeutic strategies. Researchers worldwide utilize CDR2 monoclonal antibodies to investigate neuronal development, synaptic plasticity, and cellular signaling pathways. Advanced imaging techniques combined with CDR2 monoclonal antibodies enable detailed visualization of protein localization and interactions within neural tissues. Santa Cruz Biotechnology monoclonal antibodies for CDR2 support researchers in making meaningful contributions to neuroscience research and the development of therapeutic approaches for neurological disorders.